Laurent R. Chiarelli

4.4k total citations
93 papers, 2.7k citations indexed

About

Laurent R. Chiarelli is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Laurent R. Chiarelli has authored 93 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Molecular Biology, 26 papers in Infectious Diseases and 16 papers in Organic Chemistry. Recurrent topics in Laurent R. Chiarelli's work include Biochemical and Molecular Research (31 papers), Tuberculosis Research and Epidemiology (25 papers) and Cancer therapeutics and mechanisms (19 papers). Laurent R. Chiarelli is often cited by papers focused on Biochemical and Molecular Research (31 papers), Tuberculosis Research and Epidemiology (25 papers) and Cancer therapeutics and mechanisms (19 papers). Laurent R. Chiarelli collaborates with scholars based in Italy, Russia and Slovakia. Laurent R. Chiarelli's co-authors include Giovanna Valentini, Andrea Mattevi, Maria Rosalia Pasca, Giovanna Riccardi, Alberto Zanella, Alessandro Galizzi, Silvia Buroni, Paola Bianchi, Viola Camilla Scoffone and Elisa Fermo and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Laurent R. Chiarelli

90 papers receiving 2.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laurent R. Chiarelli Italy 30 1.5k 582 444 408 291 93 2.7k
Annarita Stringaro Italy 36 1.9k 1.2× 718 1.2× 235 0.5× 579 1.4× 196 0.7× 103 4.0k
Nicholas Murgolo United States 30 1.8k 1.2× 567 1.0× 165 0.4× 476 1.2× 329 1.1× 64 4.3k
Mary E. Hensler United States 30 1.5k 1.0× 647 1.1× 376 0.8× 446 1.1× 55 0.2× 42 3.4k
Yukio Kitade Japan 32 2.5k 1.6× 378 0.6× 938 2.1× 201 0.5× 88 0.3× 245 4.1k
K.P. Battaile United States 34 2.1k 1.3× 739 1.3× 232 0.5× 182 0.4× 112 0.4× 131 3.6k
Teck Kwang Lim Singapore 28 1.2k 0.8× 216 0.4× 176 0.4× 292 0.7× 127 0.4× 78 2.5k
Glenn E. Dale Switzerland 35 1.6k 1.1× 402 0.7× 287 0.6× 395 1.0× 232 0.8× 63 3.0k
Sergey N. Kochetkov Russia 27 1.8k 1.2× 794 1.4× 492 1.1× 905 2.2× 77 0.3× 255 3.5k
Tadashi Yoshida Japan 30 902 0.6× 154 0.3× 167 0.4× 182 0.4× 114 0.4× 188 2.6k
Matthew W. Frank United States 30 1.7k 1.1× 444 0.8× 114 0.3× 470 1.2× 160 0.5× 63 2.9k

Countries citing papers authored by Laurent R. Chiarelli

Since Specialization
Citations

This map shows the geographic impact of Laurent R. Chiarelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent R. Chiarelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent R. Chiarelli more than expected).

Fields of papers citing papers by Laurent R. Chiarelli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent R. Chiarelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent R. Chiarelli. The network helps show where Laurent R. Chiarelli may publish in the future.

Co-authorship network of co-authors of Laurent R. Chiarelli

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent R. Chiarelli. A scholar is included among the top collaborators of Laurent R. Chiarelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent R. Chiarelli. Laurent R. Chiarelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mori, Matteo, Edoardo Scarpa, Giorgia Moschetti, et al.. (2025). Nanoenabling MbtI Inhibitors for Next-Generation Tuberculosis Therapy. Journal of Medicinal Chemistry. 68(5). 5312–5332. 1 indexed citations
2.
Wang, Bin, Giovanni Stelitano, Olga Riabova, et al.. (2023). Side Chain-Modified Benzothiazinone Derivatives with Anti-Mycobacterial Activity. Biomedicines. 11(7). 1975–1975. 2 indexed citations
3.
Degiacomi, Giulia, Giovanni Stelitano, Vadim Makarov, et al.. (2023). CanB, a Druggable Cellular Target in Mycobacterium tuberculosis. ACS Omega. 8(28). 25209–25220. 3 indexed citations
4.
Wang, Wenxin, Giovanni Stelitano, Olga Riabova, et al.. (2023). Benzothiozinone derivatives with anti-tubercular Activity−Further side chain investigation. European Journal of Medicinal Chemistry. 264. 115976–115976. 4 indexed citations
5.
Mori, Matteo, Stefania Villa, Laurent R. Chiarelli, Fiorella Meneghetti, & Marco Bellinzoni. (2023). Structural Study of a New MbtI-Inhibitor Complex: Towards an Optimized Model for Structure-Based Drug Discovery. Pharmaceuticals. 16(11). 1559–1559. 2 indexed citations
6.
Stelitano, Giovanni, et al.. (2023). Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options. International Journal of Molecular Sciences. 24(5). 4635–4635. 17 indexed citations
7.
Mori, Matteo, Giovanni Stelitano, Arianna Gelain, et al.. (2023). Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria. Pharmaceutics. 15(2). 502–502. 12 indexed citations
8.
Campagnoli, Monica, Paolo Iadarola, Marco Fumagalli, et al.. (2023). Could the Oxidation of α1-Antitrypsin Prevent the Binding of Human Neutrophil Elastase in COVID-19 Patients?. International Journal of Molecular Sciences. 24(17). 13533–13533. 2 indexed citations
9.
Mori, Matteo, et al.. (2022). Synthesis, crystal structure, Hirshfeld surface, computational and antibacterial studies of a 9-phenanthrenecarboxaldehyde-based thiodihydropyrimidine derivative. Journal of Molecular Structure. 1267. 133571–133571. 17 indexed citations
10.
Shi, Rui, Bin Wang, Giovanni Stelitano, et al.. (2022). Development of 6-Methanesulfonyl-8-nitrobenzothiazinone Based Antitubercular Agents. ACS Medicinal Chemistry Letters. 13(4). 593–598. 11 indexed citations
11.
Degiacomi, Giulia, Giovanni Stelitano, Josè Camilla Sammartino, et al.. (2022). The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme. International Journal of Molecular Sciences. 23(2). 771–771. 15 indexed citations
12.
Mori, Matteo, Fiorella Meneghetti, Laurent R. Chiarelli, et al.. (2022). Virtual screening and crystallographic studies reveal an unexpected γ-lactone derivative active against MptpB as a potential antitubercular agent. European Journal of Medicinal Chemistry. 234. 114235–114235. 10 indexed citations
13.
Mori, Matteo, Giovanni Stelitano, Laurent R. Chiarelli, et al.. (2021). Synthesis, Characterization, and Biological Evaluation of New Derivatives Targeting MbtI as Antitubercular Agents. Pharmaceuticals. 14(2). 155–155. 25 indexed citations
14.
Mori, Matteo, Giovanni Stelitano, Arianna Gelain, et al.. (2020). Shedding X-ray Light on the Role of Magnesium in the Activity of Mycobacterium tuberculosis Salicylate Synthase (MbtI) for Drug Design. Journal of Medicinal Chemistry. 63(13). 7066–7080. 24 indexed citations
15.
Mori, Matteo, Fiorella Meneghetti, Laurent R. Chiarelli, et al.. (2020). 6-Hydroxy-2-methylbenzofuran-4-carboxylic Acid. SHILAP Revista de lepidopterología. 2020(2). M1143–M1143.
16.
Groleau, Marie‐Christine, Laurent R. Chiarelli, Cor Ras, et al.. (2019). Phenylacetyl Coenzyme A, Not Phenylacetic Acid, Attenuates CepIR-Regulated Virulence in Burkholderia cenocepacia. Applied and Environmental Microbiology. 85(24). 10 indexed citations
17.
Saß, Andrea, Heleen Van Acker, Lisa Ostyn, et al.. (2019). Various Evolutionary Trajectories Lead to Loss of the Tobramycin-Potentiating Activity of the Quorum-Sensing Inhibitor Baicalin Hydrate in Burkholderia cenocepacia Biofilms. Antimicrobial Agents and Chemotherapy. 63(4). 17 indexed citations
18.
Chiarelli, Laurent R., Matteo Mori, Giangiacomo Beretta, et al.. (2019). New insight into structure-activity of furan-based salicylate synthase (MbtI) inhibitors as potential antitubercular agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 823–828. 27 indexed citations
19.
Pini, Elena, Giulio Poli, Tiziano Tuccinardi, et al.. (2018). New Chromane-Based Derivatives as Inhibitors of Mycobacterium tuberculosis Salicylate Synthase (MbtI): Preliminary Biological Evaluation and Molecular Modeling Studies. Molecules. 23(7). 1506–1506. 32 indexed citations
20.
Chiarelli, Laurent R., Matteo Mori, Daniela Barlocco, et al.. (2018). Discovery and development of novel salicylate synthase (MbtI) furanic inhibitors as antitubercular agents. European Journal of Medicinal Chemistry. 155. 754–763. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026